Taipei Veterans General Hospital (Taipei VGH) has entered into a new partnership with Gilead Sciences Taiwan, signing a memorandum of understanding (MOU) on clinical trial collaboration. Through the integration of expertise and resources, the two parties aim to strengthen the clinical trial environment, enhance processes, and improve execution efficiency. According to Taipei VGH Deputy Superintendent Wang Shu-Jun, the hospital has in recent years actively collaborated with both domestic and international institutions, leveraging complementary strengths and talent. The signing of this MOU will deepen their partnership and help address bottlenecks and unmet needs in clinical treatment.
Read more